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During placental development, mononuclear cytotrophoblasts differentiate and fuse to syncytiotrophoblasts (STBs) to form syncytia, which secrete human chorionic gonadotropin (hCG). Decreased maternal perfusion of the placenta, which leads to placental dysfunction, induces changes in trophoblast syncytialization. Our previous study showed that calreticulin (CRT), a Ca 2+ -binding molecular chaperone found in the endoplasmic reticulum, is expressed in the human placenta and is involved in regulating extravillous trophoblast invasion, although its role in villous trophoblasts remains unclear. In this study, we investigated the functional role of CRT in trophoblast differentiation using the human trophoblast-like cell line BeWo, in which CRT gene expression was knocked down. We found that CRT was highly expressed in human third-trimester placentas and mainly localized in STBs. The fetal growth restriction group exhibited significantly lower CRT expression levels than did the control group. In BeWo cells, CRT knockdown markedly suppressed forskolin-induced cell fusion and b-hCG secretion. As for the mechanism responsible for these effects, the cell surface expression of E-cadherin, a key adhesion molecule related to syncytialization, was decreased, and E-cadherin accumulated adjacent to the Golgi apparatus in the CRTknockdown cells, which led to dysfunctional cell-to-cell adhesion. Additionally, metabolic labeling and a pulse-chase study revealed that the protein expression of E-cadherin was suppressed at the translational level in the CRT-knockdown cells. Collectively, these results demonstrate that CRT regulates syncytialization by ensuring appropriate control of both the synthesis and transportation of E-cadherin, suggesting that CRT expression is important for placental development during pregnancy. (Endocrinology 160: [359] [360] [361] [362] [363] [364] [365] [366] [367] [368] [369] [370] [371] [372] [373] [374] 2019) I n the human placenta, appropriate syncytial development through trophoblast differentiation and the fusion of mononucleated cytotrophoblasts (CTBs) to produce multinucleated syncytiotrophoblasts (STBs) plays a crucial role in feto-maternal nutrient exchange and steroid hormone synthesis. This syncytialization is necessary for successful placental development and fetal growth (1, 2) . During the course of trophoblast syncytialization, human chorionic gonadotropin (hCG) is mainly produced by placental STBs, and hCG promotes syncytialization in an autocrine/paracrine manner (3, 4) . Decreased maternal perfusion of the placenta, which leads to several pregnancy-related disorders such as fetal growth restriction (FGR) and preeclampsia (PE), induces abnormalities in trophoblast syncytialization (5, 6) . However, the pathological mechanisms responsible for these severe complications are complex and have not been fully clarified.
Recent studies have suggested that placental endoplasmic reticulum (ER) stress is involved in the pathophysiology of human pregnancy complications (7, 8) . The ER is a critical intracellular compartment, which controls the quality of newly synthesized secretory or membrane proteins and Ca 2+ homeostasis. The folding of newly synthesized proteins is assisted by various molecular chaperones and redox-related enzymes in the ER (9) . Misfolded or unfolded proteins are transported from the ER to the cytosol for ER-associated degradation (10) . Under certain stress conditions, such as excessive protein synthesis, protein abnormalities caused by genetic mutations, disturbances of Ca 2+ homeostasis, or oxidative stress, excessive amounts of misfolded proteins are retained in the ER, triggering ER stress responses (11) . From the viewpoint of human pregnancy complications, it has been hypothesized that FGR and PE may result in ER stress, in which ER dysfunction may be associated with the pathological mechanisms responsible for placental disorders (12) (13) (14) (15) (16) (17) . However, there have not been any reports about the effects of ER stress on trophoblast syncytialization, which is a major part of placental development. Calreticulin (CRT) is an ER-resident molecular chaperone, which facilitates appropriate folding of newly synthesized glycoproteins and regulates Ca 2+ homeostasis (18) . CRT is expressed in the human placenta (19) (20) (21) (22) , and it has been reported that the level of CRT is higher in maternal blood during pregnancy than in nonpregnant women (20, 22) . Recently, we found that CRT is expressed in the human placenta throughout gestation, and CRT was shown to play a regulatory role in the invasion of extravillous trophoblasts (EVTs) using CRT-knockdown HTR8/SVneo cells. These findings suggest that CRT expression is important for placental development during early pregnancy (23) . Although there have been some reports about the role of CRT in trophoblast invasion (21, 24) , the functions of CRT in placental development are disputed, and the importance of CRT is poorly understood, especially its role in syncytialization in the placenta. Hence, the objective of this study was to investigate the expression and functional role of CRT in trophoblast syncytialization using BeWo cells (human trophoblast-like choriocarcinoma cells), in which CRT gene expression was knocked down.
Materials and Methods

Materials
The primary antibodies used in this study are as follows: anti-CRT antibodies [Stressgen, San Diego, CA; RRID: AB_ 10618853 (25) Peroxidase-conjugated antibodies against rabbit, mouse, and goat IgG were purchased from Dako. All other reagents used in this study were of high grade and were obtained from SigmaAldrich or Wako Pure Chemicals (Osaka, Japan).
Human tissue collection and sample preparation
Informed consent was obtained from individual patients for the use of the placental specimens. Third-trimester samples of the human placenta were collected during cesarean sections before the onset of labor. FGR was defined as a newborn weight of less than the 10th percentile for the infant's gestational age. PE was defined as when the patient's blood pressure was $140/ 90 mm Hg after 20 weeks of gestation and the patient exhibited proteinuria ($300 mg protein/24 h). The eligibility of the PE cases was determined according to the diagnostic criteria of the International Society for the Study of Hypertension in Pregnancy. Cases involving multiple pregnancies, fetal chromosomal abnormalities, or fetal anomalies were also excluded. For immunohistochemistry, placental tissue samples [i.e., FGR (n = 17), FGR plus PE (n = 17), and gestational age-matched controls (n = 22)] were washed in ice-cold PBS (pH 7.2), before being fixed in 4% paraformaldehyde in PBS. For immunoblot analysis, we could obtain placenta samples of FGR (n = 6) and gestational agematched controls (n = 6), and the specimens were immediately frozen in liquid nitrogen and stored at 280°C, before being used for the analysis. This study was approved by the Ethics Committee of Wakayama Medical University.
Immunohistochemistry
In the immunostaining experiments, tissue samples on slides were deparaffinized and rehydrated. Then, endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol. For antigen retrieval, the slides were boiled in 1 mM EDTA (pH 8.0) in a pressure cooker for 10 minutes. The sections were incubated with the primary antibodies-that is, the anti-CRT antibody (25) at a dilution of 1:5000 (0.2 mg/mL), the anti-CK7 antibody at a dilution of 1:1000 (concentration not available), or the anti-CD34 antibody at a dilution of 1:1000 (concentration not available). The signals were detected using the simple stain MAX PO reagent (Nichirei Biosciences, Tokyo, Japan) and 3,3
0 -diaminobenzidine as a substrate. For the negative control, a mouse isotype IgG1 antibody was used.
Counterstaining was performed with Mayer's hematoxylin solution. The results of each staining procedure were evaluated using the following semiquantitative method: The staining intensity was graded as 0 (none), 1 (weak), 2 (moderate), or 3 (strong). The percentage of positive cells was graded as: 0, no positive cells, 1, ,30%; 2, 30% to 80%; or 3, .80%. The immunoreactive score (IRS) was calculated using the following equation: IRS = staining intensity 3 percentage of positive cells, according to the method described by Kohlberger et al. (39) . The staining was graded by two observers who were not aware of the subjects' clinical data.
Cell culture
Human choriocarcinoma BeWo cells [RRID: CVCL-0044 (40)], which are widely used as a model of trophoblast differentiation and syncytialization (41, 42) , were purchased from the American Type Culture Collection (Manassas, VA) and authenticated by JCRB Cell Bank (National Institute of Biomedical Innovation Japan, report no. KBN0410). The BeWo cells were grown in RPMI 1640 medium (Wako Pure Chemicals) supplemented with 10% fetal calf serum (FCS) at 37°C in an atmosphere of 5% CO 2 and 95% air. The media included an antibiotic mixture, containing penicillin, streptomycin, and amphotericin B (Life Technologies, Carlsbad, CA).
Establishment of stable CRT-knockdown transfectants
pRS expression plasmids containing small hairpin RNA for CRT (CRT-shRNA) were obtained from OriGene Technologies (Rockville, MD). BeWo cells were transfected with plasmids with or without CRT-shRNA, using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). Stable gene transfectants were obtained after selection with puromycin (1.0 mg/mL). Two CRT-knockdown clones, in which CRT protein expression was suppressed, were isolated from the gene transfectants. The established clones were used between passages 12 and 15.
Immunoblot analysis
A total of 500 mg of human placental tissue was homogenized in 0.4 mL of RIPA buffer (Sigma-Aldrich), containing 10% SDS and protease inhibitors (4 mM Pefabloc, 1 mM pepstatin, 1 mM leupeptin, and 200 mM phenylmethylsulfonyl fluoride [Roche, Basel, Switzerland]), using a Teflon homogenizer (As One, Osaka, Japan). The homogenized samples were centrifuged at 18,000g for 10 minutes at 4°C, and supernatant samples were prepared. Alternatively, the cultured cells were lysed in lysis buffer A [10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, and protease inhibitors]. The lysate was sonicated intermittently on ice for 15 minutes, before being centrifuged at 10,000g for 10 minutes at 4°C. The supernatant extracts were separated by 7.5% or 10% SDS-PAGE and transferred onto nitrocellulose membranes (Immobilon-P, Millipore). After being blocked with 5% skimmed milk in lysis buffer A, the membranes were incubated at 4°C overnight with the primary antibodies in blocking buffer; that is, the anti-CRT antibody (25) at a dilution of 1:10,000 (0.1 mg/mL), the anti-BiP antibody at a dilution of 1:1000 (0.2 mg/mL), the anti-CNX antibody at a dilution of 1:5000 (0.2 mg/mL), the antiERp57 antibody at a dilution of 1:5000 (0.2 mg/mL), the anti-E-cadherin antibody at a dilution of 1:3000 (0.08 mg/mL), the anti-b-catenin antibody at a dilution of 1:4000 (14.0 mg/mL), the anti-GAPDH antibody at a dilution of 1:4000 (0.25 mg/mL), the anti-GM130 antibody at a dilution of 1:5000 (0.02 mg/mL), the anti-TGN46 antibody at a dilution of 1:2000 (0.33 mg/mL), or the anti-Na + /K + ATPase antibody at a dilution of 1:2000 (0.5 mg/mL). The membranes were then incubated with a peroxidase-conjugated secondary antibody. The blotting signals were detected using the Immobilon Western Chemiluminescent horseradish peroxidase substrate (Millipore). The results were quantified densitometrically using ImageJ version 1.50b (National Institutes of Health, Bethesda, MD). GAPDH was used as a loading control.
RT-PCR and real-time quantitative RT-PCR
Total RNA was obtained from BeWo cells using TRIzol reagent (Thermo Fisher Scientific). RT-PCR was performed using the PrimeScript One Step RT-PCR kit version 2 (Takara Biomedicals, Shiga, Japan). The oligonucleotide sequences of the primers used for the RT-PCR amplification procedures are listed in Table 1 . The PCR products were electrophoresed on 1.5% agarose gel, and the bands were visualized via ethidium bromide staining.
Real-time quantitative RT-PCR (RT-qPCR) was carried out with a CFX96 Touch real-time system (Bio-Rad Laboratories, Hercules, CA) and a One Step SYBR PrimeScript RT-PCR kit (Perfect Real Time, Takara Biomedicals). The oligonucleotide sequences of the primers used for the RT-qPCR amplification procedures are listed in Table 2 . All of the RT-qPCR experiments were performed in triplicate. The data were processed using Bio-Rad CFX Manager version 3.1 (Bio-Rad Laboratories), and expression levels were calculated via the comparative DDCt method using GAPDH as reference RNA.
Cell differentiation assay
Cells were grown on coverslips in six-well culture plates and cultured for 24 hours. Then, the cells were further cultured with an optimized concentration of forskolin (80 mM), whereas the vehicle control was treated with DMSO. At each time point, the conditioned medium was harvested and the cells were processed for b-catenin staining. Cell nuclei were stained with Hoechst 33342 (Invitrogen). The stained cells were viewed using laser scanning confocal microscopy (LSM700 Zen; Carl Zeiss, Jena, Germany) and analyzed using the LSM software ZEN 2012. In each experimental group, the number of fused cells was counted in 8 to 10 randomly selected microscopic fields. In each microscopic field, the number of nuclei in STB-like fused cells and the total number of nuclei were counted. Then, the percentage 
of fused cells was calculated as the ratio of the total number of nuclei in the STB-like fused cells to the total number of nuclei in the microscopic field, multiplied by 100.
Immunoradiometric assay
Cell culture-conditioned medium was centrifuged at 10,000g for 10 minutes to remove any cell debris and stored at 280°C until use. b-hCG secretion was determined by measuring the concentration of b-hCG in the conditioned medium using an immunoradiometric assay kit (CIS Bio International, Gif-surYvette, France), according to the manufacturer's instructions. The examination was outsourced to LSI Medience Corporation (Tokyo, Japan).
Cell proliferation
A total of 7.5 3 10 3 cells were placed in 100 mL of medium in 96-well plates and cultured as described above. Then, the cells were fixed with 4% paraformaldehyde in PBS and stained with 0.01% crystal violet. The stained cells were lysed with 100 mL of lysis buffer B (10% SDS and 10 mM HCl), and the number of cells was estimated photometrically by measuring the absorbance of the lysate at 595 nm using a microplate reader.
Immunoprecipitation
Cell lysates containing 1.0 mg of protein were incubated with the anti-E-cadherin antibody at 4°C for 2 hours, before being incubated with protein G-Sepharose beads (Thermo Scientific) overnight. After being washed with lysis buffer A, the immunoprecipitates were released from the beads by heating them in SDS sample buffer (1% SDS and 10 mM dithiothreitol) at 95°C for 10 minutes. Then, the immunoprecipitated samples were used in the subsequent experiments.
Immunofluorescence microscopy
Cells were fixed in 4% paraformaldehyde, permeabilized with 1% Triton X-100 in PBS for 10 minutes, and then incubated with specific primary antibodies, that is, the anti-CRT antibody (26) at a dilution of 1:300 (3.3 mg/mL), the anti-CNX antibody at a dilution of 1:200 (5.0 mg/mL), the anti-Ecadherin antibody at a dilution of 1:200 (1.25 mg/mL), the anti-b-catenin antibody at a dilution of 1:2000 (28.0 mg/mL), the anti-GM130 antibody at a dilution of 1:200 (0.6 mg/mL), or the anti-TGN46 antibody at a dilution of 1:300 (2.2 mg/mL). The primary antibodies were labeled with secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 555 (Invitrogen) and visualized and analyzed by laser scanning confocal microscopy, as described above.
Biotinylation of cell-surface proteins and avidin pull-down
After being washed with cold PBS, cell surface proteins were biotinylated by incubating cells with 1.0 mg/mL EZ-Link Sulfo-NHS-SS-Biotin (Thermo Scientific) in PBS for 30 minutes at 4°C with gently rocking. The biotinylation reaction was quenched with 100 mM Tris-Cl (pH 7.4) in cold PBS. Then, the cells were rinsed with cold PBS and lysed in lysis buffer A. The lysate samples were subjected to immunoblot analysis, as described above.
Subcellular fractionation using sucrose-gradient ultracentrifugation
Cells were homogenized with homogenization buffer [10 mM HEPES (pH 7.0), 0.25 M sucrose, 2 mM EGTA, and protease inhibitors]. The resultant homogenates were centrifuged at 10,000g for 10 minutes at 4°C, and the postnuclear supernatant (0.5 mL) was added to 1.5 mL of a sucrose gradient [0.4, 0.6, 0.8, 1.0, 1.4, and 1.8 M sucrose in 10 mM HEPES (pH 7.0) and 2 mM EGTA], before being centrifuged at 55,000g for 2 hours at 4°C. Fractions of 0.8 mL were collected from the top to the bottom and used for the subsequent experiments.
Protein stability assay
Cells were plated on six-well plates and allowed to adhere for 24 hours. Cycloheximide was added to the culture medium at a concentration of 10 mg/mL for the indicated time periods (0, 2, 4, and 8 hours). The cells were then lysed, and the levels of E-cadherin protein were examined by immunoblot analysis. The results were quantified densitometrically, as described above. GAPDH was used as a loading control. The band intensity of the 0-hour control was considered to represent an expression level of 100%, and the detected level of E-cadherin was shown as a ratio to that of the 0-hour control for each time point.
Metabolic labeling and pulse-chase study Cells were grown on coverslips in six-well culture plates and cultured for 24 hours. After 24 hours, the cells were preincubated for 2 hours at 37°C with methionine-free DMEM (Life Technologies) supplemented with dialyzed 10% FCS. For protein labeling, L-[
35 S]methionine/cysteine (Perkin Elmer, Waltham, MA) was added to the culture media at a concentration of 125 mCi/mL and incubated for 15 minutes at 37°C. After being rinsed with DMEM supplemented with 10% nondialyzed FCS, the cells were incubated for 8 hours in DMEM supplemented with 10% nondialyzed FCS for the pulse-chase studies. At the various incubation time points (0, 1, 2, 4, and 8 hours), the E-cadherin molecules that were immunoprecipitated from the cell lysates were subjected to SDS-PAGE with 4% to 20% gradient gel. After electrophoresis, the gel was completely dried using RapiDry (ATTO, Tokyo, Japan; model AE-3750), and samples of the gel were applied to an imaging plate (BAS-MP2040; Fuji Photo Film, Tokyo, Japan) and exposed for 3 days. The imaging plate was analyzed using BAS-2500 (GE Healthcare, Chicago, IL), and the level of E-cadherin was quantified using the Multi Gauge software (GE Healthcare). Additionally, to assess the intracellular levels of protein translation occurring, cell lysates were prepared from cells that had been labeled with L-[
35 S]methionine/cysteine for 
GAGTCAACGGATTTGGTCGT GACAAGCTTCCCGTTCTCAG Figure 1 . The expression of CRT in the human placenta. (a) The expression of CRT in human placental samples from the third (37 to 40 wk) trimester was examined by immunoblot analysis with an anti-CRT antibody. For quantification, placental samples from FGR-associated placentas (n = 6) and the placentas of gestational age-matched controls (n = 6) were examined by immunoblot analysis. Band intensity was quantified as described in "Materials and Methods." Data are shown as the mean 6 SD. *P = 0.00087 vs the control group. (b) CRT expression in thirdtrimester (38 wk) placental sections was assessed immunohistochemically (original magnification, 3100). CRT was mainly expressed in STBs, but was also detected in EVTs in the decidua and the chorionic membrane. (c) The expression of CRT, CK7, and CD34 in third-trimester (38 wk) placental sections (original magnification, 3400) was immunohistochemically assessed. CK7 staining was performed to indicate the locations of STBs, and CD34 staining was conducted to indicate the locations of endothelial cells. CRT was mainly expressed in STBs. Control immunostaining was performed with mouse nonspecific IgG1 antibodies (negative control). CRT was mainly expressed in STBs, but was also detected in endothelial cells (arrowheads) and villous macrophages (arrows). (d) Placental CRT expression was subjected to immunohistochemical grading 15 minutes, as described above. Then, cellular proteins were precipitated by adding trichloroacetic acid at a final concentration at 20%. After being centrifuged, the precipitate was washed twice in acetone. The precipitate was then dissolved and heated at 95°C for 10 minutes. Five-microgram aliquots of each of the precipitate samples were spotted onto Whatman filter membranes (GE Healthcare) with a dot blot apparatus, and the blots were applied to the imaging plate and exposed for 6 hours. Then, the resultant autoradiograph was analyzed, as described above.
Cell aggregation assay
The effect of ECCD-2 (Takara Biomedicals), a rat monoclonal antibody against E-cadherin, on cell aggregation was examined, as described previously (43) . The cells were washed once with PBS and washed twice with the assay buffer (RPMI 1640 medium, containing 2 mM CaCl 2 ), resuspended in 300 mL of assay buffer, and transferred into each well of a 48-well plate. Control IgG or ECCD-2 was added to each well at 1, 2, 5, or 10 mg/mL in triplicate. The cells were incubated for 60 minutes and subjected to occasional shaking at 37°C. Then, an equal volume of 8% paraformaldehyde in PBS was added to each well, and the plates were centrifuged for fixation. The cells were photographed at random through a phase-contrast microscope (Nikon, Tokyo, Japan) to count the numbers of single cells or cells in aggregates (of three or more cells). After counting the number of cells, cell aggregation was assessed as the ratio of the number of cells in aggregates to the total number of cells.
Statistical analysis
Data are presented as means with SDs. The statistical analyses were performed using the Student t test or one-way ANOVA with a Bonferroni multiple comparisons test. P values of ,0.05 were considered significant.
Results
Expression of CRT in the human placenta
First, we examined placental CRT protein expression using immunoblot analysis in the cases with control (n = 6) and FGR (n = 6). CRT protein expression was detected as a single band at 55 kDa in the placentas of the control and FGR groups [ Fig. 1(a) ]. CRT was strongly expressed in both groups, but its expression level was significantly lower in the FGR group than in the controls. To explore the localization of CRT, immunohistochemical analysis was carried out in placental tissue from the third trimester. CRT was mainly expressed in the cytoplasm of STBs [ Fig. 1(b) ]. We also detected CRT expression in endothelial cells and villous macrophages (Hofbauer cells) in the villous cores, EVTs in the decidua and the chorionic membrane, and also very weakly in connective tissue cells of the amnion layer of the external membranes in the third-trimester placentas [ Fig. 1(b) and 1(c) ]. To compare the expression levels of CRT in the control (n = 22), FGR (n = 17), and FGR plus PE group placentas (n = 17), immunostaining grading was performed as described in "Materials and Methods" [ Fig. 1(d) ]. CRT expression was significantly lower in the FGR-associated groups than in the control group, which was consistent with the results of the immunoblot analysis [ Fig. 1(a) and 1(d) ].
Stable knockdown of CRT expression in BeWo cells
To investigate the function of CRT in BeWo cells, stable CRT-knockdown cell lines were established by transfecting cells with a CRT-shRNA expression vector. The RT-PCR analysis showed that compared with the parental cells [wild-type (WT)] and the cells transfected with the control vector (control-shRNA), CRT mRNA expression had been downregulated in the cells transfected with the CRT-shRNA expression vector (CRTshRNA1 and CRT-shRNA2) [ Fig. 2(a) ]. The expression of the CRT protein was also suppressed in the CRTknockdown cells [ Fig. 2(b) ]. As shown in Fig. 2(c) , transfection with either vector had no effect on cellular morphology. There were no significant differences in cell proliferation between the CRT-knockdown cells and the control-shRNA cells, although it was suppressed in all of the vector-transfected cells compared with the nontransfected WT cells [ Fig. 2(d)] .
Next, the expression of CRT and other ER-resident proteins (e.g., BiP, CNX, and ERp57) was examined by immunoblot analysis. CRT was detected as a 55-kDa protein in the control cells, and its expression was markedly suppressed in the CRT-knockdown cells [ Fig. 2(e) ]. Other chaperones, such as BiP, CNX, and ERp57, were expressed at similar levels in all cells. Alternativley, E-cadherin was detected as a 120-kDa protein, and the expression of E-cadherin was suppressed in the CRTknockdown cells compared with the control cells. To investigate the physiological roles of CRT in trophoblast differentiation, we used CRT-knockdown BeWo cells for the subsequent studies.
The stable knockdown of CRT suppressed forskolin-induced cellular fusion and induced b-hCG expression in BeWo cells
To investigate the effects of CRT knockdown on forskolininduced cellular fusion, the control and CRT-knockdown (original magnification, 3100) . The grading was performed as described in "Materials and Methods": grade 1 (no or weak staining and scarcely positive), grade 2 (moderately stained and focally positive), or grade 3 (strongly stained and diffusely positive). The IRS was calculated as described in "Materials and Methods." To determine the IRS, third-trimester (37 to 40 wk) placental samples from cases involving FGR (n = 17), both FGR and PE (n = 17), and gestational age-matched controls (n = 22) were examined by immunohistochemistry. Data are shown as the median. *P = 0.00022 vs the control group; **P = 0.0035 vs the control group.
BeWo cells were subjected to immunofluorescence microscopy. The cells were treated with an optimized concentration of forskolin (80 mM) for 24 or 48 hours. In the cells subjected to 48-hour forskolin treatment, CRT immunoreactivity exhibited a perinuclear reticular pattern, that is, an ER pattern [ Fig. 3(a) ]. The CRT signal intensity was lower in the CRTknockdown cells than in the control cells. Compared with the control cells, the fusion capacity of the CRT-knockdown cells was significantly reduced after 48-hour forskolin treatment [ Fig. 3(b) ]. After 24-or 48-hour treatment with forskolin, quantitative RT-PCR analysis of the CRT-knockdown BeWo cells revealed a significant reduction in the b-hCG transcript level [ Fig. 3(c) ]. Additionally, a concomitant reduction in the level of secreted b-hCG was also observed in the CRT-knockdown cells compared with the control cells [ Fig. 3(d) ].
The knockdown of CRT affected the expression and intracellular localization of E-cadherin E-cadherin is a transmembrane protein involved in cell-to-cell adhesion; that is, it promotes the formation of adherens junctions, which is crucial for human trophoblast syncytialization (44) . Therefore, we investigated how the knockdown of CRT affects E-cadherin in BeWo cells.
In the WT and control-shRNA cells, E-cadherin immunoreactivity was evenly distributed in the ER, cytoplasm, and plasma membrane [ Fig. 4(a) ]. In contrast, the E-cadherin signals were weaker in the ER, cytoplasm, and plasma membrane, but marked accumulation of such signals was seen around the nucleus in the CRT-shRNA2 The CRT protein levels of the WT, control, and CRT-knockdown cells were assessed using immunoblot analysis involving an anti-CRT antibody. The level of GAPDH is shown as a loading control. Band intensity was quantified as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. *P , 0.05 vs WT or control-shRNA. (c) WT, control, and CRT-knockdown cells were imaged using phase-contrast microscopy (original magnification, 3100; scale bars, 100 mm). (d) Cell number estimates were obtained at 24, 48, and 72 h after plating. Cellular proliferation was estimated photometrically by measuring the absorbance of the WT, control, and CRT-knockdown cells at 595 nm. Data represent the mean 6 SD of three independent experiments. *P , 0.05 vs the same time point for the control-shRNA or CRT-knockdown cells. (e) The expression levels of CRT, BiP, CNX, ERp57, E-cadherin, b-catenin, and GAPDH in the WT, control, and CRT-knockdown cells were assessed using immunoblot analysis with specific antibodies. doi: 10.1210/en.2018-00868 https://academic.oup.com/endocells. E-cadherin did not colocalize with CNX [an ER marker; Fig. 4(a) ], but it did colocalize with GM130 [a cis-Golgi marker; Fig. 4(b) ] and TGN46 [a trans-Golgi marker; Fig. 4(c) ].
Next, we investigated whether the knockdown of CRT affects the cell surface expression of E-cadherin by detecting E-cadherin in biotinylated cell surface proteins, as described in "Materials and Methods." A reduction in Figure 3 . Effects of the knockdown of CRT expression on forskolin-induced cell fusion and b-hCG synthesis in BeWo cells. (a) WT, control, and CRT-knockdown cells were treated with forskolin (80 mM) for 48 h. Then, the intracellular localization of b-catenin (green) and CRT (red) was examined using immunofluorescence microscopy with specific antibodies, as described in "Materials and Methods" (original magnification, 3400). Cell nuclei were stained with Hoechst 33342 (blue). b-Catenin staining was used to indicate the cytoplasmic membrane. (b) WT, control, and CRT-knockdown cells were treated with forskolin (80 mM) or dimethyl sulfoxide for 48 h, and then cell differentiation was evaluated as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. *P , 0.05 vs WT or controlshRNA. (c) After 24-or 48-h treatment with forskolin (80 mM), the transcriptional levels of b-hCG were examined in WT, control, and CRTknockdown cells using RT-qPCR, as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. *P , 0.05 vs WT or control-shRNA. (d) After 24-or 48-h treatment with forskolin (80 mM), the b-hCG secretion levels of WT, control, and CRTknockdown cells were examined using an immunoradiometric assay, as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. *P , 0.05 vs WT or control-shRNA.
cell surface E-cadherin expression was detected in the CRT-shRNA2 cells compared with the controls [Fig. 4(d) ]. In the subcellular fractions obtained after sucrose-gradient ultracentrifugation of the lysate of the CRT-shRNA2 cells, it was found that E-cadherin expression was decreased in the plasma membrane fractions [fractions 4 and 5; E-cadherin colocalized with Na + /K + ATPase, a cell-surface protein marker; Fig. 4(e) ], which was consistent with the results shown in Fig. 4(d) .
Additionally, E-cadherin expression was increased in the cis-Golgi fractions [fractions 9 and 10; E-cadherin colocalized with GM130 a cis-Golgi protein marker; , the intracellular localization of E-cadherin (green) and CNX (red) was examined in WT, control-shRNA, and CRT-shRNA2 cells using immunofluorescence microscopy with specific antibodies, as described in "Materials and Methods." CNX was stained as a location marker of the ER. Original magnification, 3400. (b) After 48-h treatment with forskolin, the intracellular localization of E-cadherin (green) and GM130 (red) was examined using specific antibodies, as described in (a). GM130 was stained as a location marker of the cis-Golgi. (c) After 48-h treatment with forskolin, the intracellular localization of E-cadherin (green) and TGN46 (red) was examined using specific antibodies, as described in (a). TGN46 was stained as a location marker of the trans-Golgi. (d) The cell surface expression of E-cadherin was examined in the control-shRNA and CRT-shRNA2 cells using the protein biotinylation and avidin pull-down assays, as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. *P , 0.05 vs control-shRNA. (e) The subcellular fractionation of the control-shRNA and CRTshRNA2 cell lysates was conducted via discontinuous sucrose density-gradient centrifugation. The cell lysates were separated into 12 fractions (F), as described in "Materials and Methods." The expression levels of E-cadherin, Na + /K + ATPase (cell surface), TGN46 (trans-Golgi), GM130 (cisGolgi), CNX, CRT, and BiP (ER) were examined in the control-shRNA and CRT-shRNA2 cells, using immunoblot analysis and specific antibodies (fractions 2 to 3; trans-Golgi; fractions 4 to 6, plasma membrane; fractions 8 to 10, cis-Golgi; fractions 9 to 12, ER). Fig. 4(e) ]. Taken together with the morphological findings, these results suggest that appropriate cellular transport of E-cadherin might be abrogated by CRT knockdown, resulting in E-cadherin accumulation in the cis-Golgi and a reduction in its cell surface expression in CRT-knockdown cells.
CRT knockdown did not affect the stability of E-cadherin
Because we found that the expression level of E-cadherin was decreased in the CRT-knockdown cells, we next tried to investigate the mechanism responsible for the observed downregulation of E-cadherin expression. RT-PCR analysis indicated that similar E-cadherin mRNA expression levels were seen in all cells, suggesting that the transcriptional expression of E-cadherin was not altered by CRT knockdown [ Fig. 5(a) ]. To investigate whether the reduction in E-cadherin expression was due to altered protein stability, CRT-knockdown and control BeWo cells were subjected to a protein stability assay, as described in "Materials and Methods." In CRT-shRNA2 cells that had not been treated with cycloheximide, a protein synthesis inhibitor, the expression level of E-cadherin was 65% of that seen in the control-shRNA cells [ Fig. 5(b) ]. After 8 hours of treatment with cycloheximide, the levels of E-cadherin had decreased to 55% 6 8% and 56% 6 5% of the corresponding initial levels in the control-shRNA cells and CRT-shRNA2 cells, respectively [ Fig. 5(b) ]. Taken together, these results indicate that the level of E-cadherin was initially suppressed in the CRT-knockdown cells, but was decreased by cycloheximide to a similar extent to that seen in the control cells, suggesting that the knockdown of CRT does not affect the degradation or stability of E-cadherin in BeWo cells.
CRT knockdown affected the translation of E-cadherin
The turnover of the E-cadherin protein was also examined by pulse-chase analysis. The control-shRNA and CRT-shRNA2 cells were pulse labeled with [ 35 S]methionine and cysteine, before being chased for 8 hours. E-cadherin was immunoprecipitated at the indicated time points using specific antibodies, and the immunoprecipitates were separated by SDS-PAGE, before being subjected to autoradiography. E-cadherin was initially produced in its 130-kDa precursor form at 0 hours [ Fig.  6(a) ] (pre-E-cadherin, arrow). The size of the E-cadherin band shifted to 120 kDa (the mature form, arrowhead) after 1 hour of chasing. The intensity of the E-cadherin band was quantified, and the total values were obtained as the sum of those with the precursor and the mature E-cadherin. The results showed that it gradually decreased to 33.5% 6 13.5% and 28.4% 6 14.7% of the corresponding levels for pre-E-cadherin (0 hours) in the control-shRNA cells and CRT-shRNA2 cells, respectively. These findings are consistent with the results of the stability assay using cycloheximide [ Fig. 5(b) ]. The overall level of protein translation was estimated with dot blots by measuring the metabolic radiolabeling efficiency of all cellular proteins, as described in "Materials and Methods." As a result, it was shown that in the CRT-shRNA2 cells, the overall protein translation level was suppressed to 72% of that seen in the control-shRNA cells [ Fig. 6(b) ].
CRT knockdown affected the cell aggregation of BeWo cells
It was reported that inhibitory antibodies against E-cadherin disrupted the aggregation of mononuclear CTBs during human placental development, resulting in a disturbance of trophoblast syncytialization (44) . To Control-shRNA and CRT-shRNA2 cells were treated with cycloheximide (CHX; 10 mg/mL) for the indicated periods of time and then were examined by immunoblot analysis. Band intensity was quantified as described in "Materials and Methods." Data are shown as the mean 6 SD of three independent experiments. determine whether decreased E-cadherin expression was involved in the observed reduction in the cell-to-cell adhesion of CRT-knockdown cells, cell aggregation was assessed using an inhibitory antibody against E-cadherin (i.e., ECCD-2) that blocks E-cadherin-mediated adhesion (Fig. 7) . The baseline level of cell-to-cell aggregation was significantly lower in the CRT-shRNA2 cells than in the control-shRNA cells. Cell aggregation was not inhibited by the control rat IgG antibody at any concentration in either the control-shRNA or CRT-shRNA cells. In the control-shRNA cells, the cell aggregation level was reduced from 70% to 30% by treatment with the ECCD-2 antibody in a dose-dependent manner. Meanwhile, in the CRT-shRNA2 cells, the cell aggregation level decreased from 30% to 15% after the addition of 1 mg/mL ECCD-2, but no further reduction was observed after treatment with an excess amount of ECCD-2 (e.g., 10 mg/mL). The 30% aggregation value obtained for the control cells treated with ECCD-2 was similar to that obtained for the CRTshRNA cells that were not treated with any antibodies. These results suggest that the aggregation of BeWo cells depends on adhesion through E-cadherin. Furthermore, Figure 6 . Effects of CRT knockdown on the synthesis and turnover of E-cadherin in BeWo cells. (a) Control-shRNA and CRT-shRNA2 cells were pulse labeled with [ 35 S]methionine/cysteine for 15 min and then chased for 8 h. E-cadherin was immunoprecipitated from the cell lysates at the indicated time points, before being subjected to SDS-PAGE, followed by autoradiography, as described in "Materials and Methods." The positions of the precursor and mature forms of E-cadherin are indicated by the arrow and arrowhead, respectively. The intensity of each band was quantified, and the resultant data are shown as the mean 6 SD of three independent experiments. (b) Control-shRNA and CRT-shRNA2 cells were pulse labeled for 15 min as shown in (a), and then the level of total protein synthesis was evaluated by dot blot analysis using wholecell lysates, as described in "Materials and Methods." The dot intensity was quantified, and the resultant data are shown as the mean 6 SD of three independent experiments. the difference in cell-to-cell aggregation between the control and CRT-knockdown cells might have been due to reduced cell surface expression of E-cadherin in the CRTknockdown cells.
Discussion
In this study, we showed that CRT plays a regulatory role in trophoblast syncytialization through its control of E-cadherin protein synthesis and transportation, suggesting that CRT expression is important for placental development during pregnancy.
CRT is an ER-resident molecular chaperone and plays a variety of roles in cell growth, differentiation, and apoptosis, cancer biology, and immunity (18, 45, 46) . Although it is known that CRT is expressed in human choriocarcinoma cell lines and the human placenta (19, 47) , there have only been a few reports about the functional roles of CRT in human placentation or pregnancy-related disorders. Our recent study showed that CRT was strongly expressed in placental tissues during normal pregnancy from the first to the third trimester (23) , which was consistent with the findings of other studies involving human third-trimester placentas (19) (20) (21) (22) . Indeed, in the previous report, we reported the functional role of CRT in a "trophoblast invasion" step utilizing HTR8/SVneo cells, and under the conditions with CRT knockdown, cell invasion ability of HTR8/ SVneo cells was suppressed by decreased cell adhesion through dysfunction of integrins with altered Nglycosylation (23) . In the current study, we clarified the functional role of CRT in a "trophoblast syncytialization" step utilizing forskolin-treated BeWo cells. To the best of our knowledge, the current study is the first to reveal the role of CRT in trophoblast syncytialization, which might lead to further novel findings of the role of CRT in placental development.
As for pregnancy-related disorders, Shi et al. (21) reported that compared with control placentas, the expression of CRT was elevated in third-trimester placentas affected by PE, and increased in accordance with the severity of symptoms, whereas Gu et al. (20) showed that placental CRT expression did not differ between PE and control pregnancies. Alternatively, Crawford et al. (22) reported that immunoblot analysis demonstrated that placental CRT expression did not differ between FGR and control pregnancies, which is not consistent with our findings, that is, that placental CRT expression was downregulated in the FGR group [ Fig. 1(a) ]. This discrepancy might have been due to the methods used to sample placental tissue, which is composed of heterogeneous types of cells derived from the mother or embryo. In the current study, we investigated CRT localization in the third trimester and compared CRT expression between FGR-associated and control pregnancies using an immunohistochemical method. In the third-trimester placenta, we detected similar levels of EVT CRT expression in the decidua and chorionic membrane, whereas CRT was strongly expressed in the cytoplasm of STBs in the control group [ Fig. 1(b) ]. The FGR-associated group exhibited significantly lower STB CRT expression than did the control group [ Fig. 1(d) ], which is consistent with the results of our immunoblot analysis. It was reported that CTBs that were isolated from FGR-associated placentas displayed a deficiency of in vitro syncytialization and reduced b-hCG secretion (5) , and histological analysis of the FGR-associated placentas revealed more CTBs and a reduced STB/CTB ratio, which were indicative of insufficient syncytialization (48) . Thus, we investigated the physiological functions of CRT in placental development using the human trophoblast-like cell line BeWo, an established in vitro model for studying trophoblast syncytialization (41, 42) .
In syncytialization, CTBs differentiate into STBs. Syncytialization starts at the time of implantation during placental development and continues until the end of pregnancy. Syncytialization can be experimentally induced in trophoblasts in vitro by using cAMP analogs or enhancers of cAMP synthesis (e.g., forskolin) (1, 2). b-hCG, which is an important gestational hormone, is considered to be a biochemical marker of syncytialization, because it is synthesized by STBs. Additionally, b-hCG stimulates adenylyl cyclase to increase the level of cAMP, which promotes CTB differentiation in an autocrine/paracrine manner (4, 49) . In the current study, we established stable CRT-knockdown BeWo cell lines by transfecting cells with a CRT-shRNA expression vector to investigate the functional role of CRT in trophoblast differentiation. Although cell proliferation was suppressed in all of the vector-transfected cells compared with the nontransfected WT cells, which might be due to the effect by shRNA transfection procedure, there were no significant differences in cell proliferation between the CRT-knockdown cells and the control-shRNA cells [ Fig. 2(d) ]. Thus, we compared mainly CRT-knockdown cells and the control-shRNA cells in this study. CRTknockdown cells exhibited a significantly reduced capacity for forskolin-induced cell fusion [ Fig. 3(b) ], and we also found that the cellular expression and secretion of b-hCG were suppressed [ Fig. 3(d) ]. These results indicate that CRT expression is required for STB production via the fusion of CTBs (syncytialization) and the expression and secretion of b-hCG, suggesting that CRT is physiologically important for syncytialization during placental development.
So, by what mechanism is CRT involved in the regulation of syncytialization in trophoblast cells? In syncytialization, it is known that the cell-to-cell fusion of CTBs is controlled via alterations in E-cadherin, which is a transmembrane adhesion molecule that contributes to cell-to-cell adhesion by promoting the formation of adherens junctions (44, 50) . In human CTB cultures, E-cadherin expression increases until 24 hours, which coincides with the maximal formation of CTB aggregates, and after this, E-cadherin expression decreases during the period of cell fusion (44, 50, 51) . Furthermore, inhibitory antibodies against E-cadherin blocked human trophoblast syncytialization by disrupting the aggregation of mononuclear CTBs, and this finding strongly indicated that E-cadherin mediates mononuclear cell aggregation, which is the first step in syncytialization (44) . However, it remains unclear how E-cadherin expression is regulated and how it is involved in trophoblast cell fusion during syncytialization. In the current study, we demonstrated that the expression of E-cadherin was reduced on the surfaces of CRT-knockdown cells [ Fig.  4(b) ]. Additionally, in a cell aggregation assay using an inhibitory antibody against E-cadherin, we found that E-cadherin contributed markedly to cell-to-cell adhesion in the control BeWo cells (Fig. 7) . However, in the CRTknockdown cells, cell aggregation was markedly suppressed, and cell aggregation was also less dependent on E-cadherin in the CRT-knockdown cells than in the control cells. Collectively, these results indicated that in BeWo cells CRT knockdown caused a reduction in cell surface E-cadherin expression, resulting in dysfunctional cell-to-cell adhesion, a pivotal initial process in trophoblast syncytialization.
In the current study, we also investigated how CRT knockdown downregulates the expression of E-cadherin in BeWo cells. Compared with the control cells, the expression of E-cadherin was suppressed in the CRTknockdown cells at the protein level [ Fig. 5(b) ], but not at the transcriptional level [ Fig. 5(a) ]. In our previous study, we found that the ectopic overexpression of the CRT gene in Madin-Darby canine kidney (MDCK) renal epithelial cells caused the downregulation of E-cadherin at the transcriptional level by upregulating the expression of Slug, a repressor molecule that binds to the E-cadherin gene (52) . Although it is unclear whether previous findings are compatible with the results of the current study, the results we obtained using CRT-knockdown BeWo cells suggested that the observed reduction in E-cadherin might have been regulated through changes in protein degradation, stability, or translation, but not changes in transcription. Therefore, we examined the synthesis and stability of E-cadherin in the control and CRT-knockdown cells using metabolic labeling experiments. The results showed that there was no difference in the rate of cycloheximide-induced E-cadherin degradation between the control and CRT-knockdown cells [ Fig. 5(b) ], suggesting that CRT knockdown did not enhance the degradation or stability of the E-cadherin protein. Alternatively, pulse-chase analysis showed that the level of protein synthesis was markedly suppressed in the CRT-knockdown cells compared with the controls [ Fig. 6(b) ]. Furthermore, in the CRT-knockdown cells, the initial level of labeled E-cadherin was suppressed to 65% of that seen in the control cells [ Fig. 6(a) ]. However, in the pulse-chase analysis, the E-cadherin level was decreased to similar extents in both the control and CRTknockdown cells in a time-dependent manner [ Fig. 6(a) ]. Taken together, these results indicated that in the CRTknockdown cells, the expression level of E-cadherin was suppressed at the translational level, but comparable levels of E-cadherin degradation were occurring in the control and CRT-knockdown cells. Additionally, several studies demonstrated that ER stress-induced translational inhibition is involved in the pathological process in placental tissues of FGR (12, 53) . Upregulated ER stress responses are linked to the translational inhibition of proteins via the inactivation of eukaryotic initiation factor a (54, 55) . CRT is a member of ER-resident molecular chaperone, which works to decrease the unfolded protein accumulation under the ER stress (18) . Thus, such translational inhibition might be partly due to the suppression of CRT expression in placental tissues in cases of FGR. However, it is not known how CRT knockdown downregulates the translation levels of various proteins, including E-cadherin. Further investigation is required to clarify the functions of CRT in protein synthesis and the associated regulatory mechanisms.
During the reduction in cell-surface E-cadherin expression, we detected the accumulation of E-cadherin adjacent to Golgi complexes in the CRT-knockdown cells. In the ER, cell surface membrane proteins are initially subjected to quality control processes, before undergoing appropriate folding with the help of various molecular chaperones and folding-related enzymes, such as BiP, CNX, CRT, protein disulfide isomerase, and ERp57 (56). The folded proteins are then transported from the ER to the Golgi complex to undergo maturation; that is, they undergo further posttranslational modifications, such as glycosylation and lipidation, before eventually being transported from the work to the destination membrane using secretory vesicles. In the most polarized epithelial cells, E-cadherin localizes in the basolateral plasma membrane, and it is trafficked through the ER and trans-Golgi network en route to the membrane (57) . In agreement with our findings, there have been some reports about dysfunctional E-cadherin transportation leading to the accumulation of the molecule adjacent to the Golgi complex (57-59). Farr et al. (57) reported that the delivery of newly synthesized E-cadherin to the cell surface membrane was prevented, leading to its accumulation to the Golgi complex, by low-temperature treatment at 14°C in MDCK cells. Lohia et al. (58) reported that the depletion of Scribble, a polarity protein that controls E-cadherin traffic, enhanced E-cadherin accumulation to the Golgi complex in MDCK cells. Alternatively, Kajiho et al. (59) reported that Rab2A, a protein that is essential for ER-to-Golgi transport, regulates the Golgi transportation of E-cadherin in breast cancer cell lines. The overexpression of Rab2A led to the accumulation of E-cadherin in perinuclear vesicular structures, which colocalized with TGN46 and GM130, but not with CNX, in the ER, which is similar to the findings we obtained with CRTknockdown BeWo cells [ Fig. 4(a)-4(c) ], providing a plausible explanation for the disturbed Golgi-to-plasma membrane trafficking of E-cadherin. Taken together with the results of the present and previous studies, we hypothesize that CRT plays a regulatory role in appropriate E-cadherin cell surface distribution and trafficking in trophoblast cells, which is essential for syncytialization via cell-to-cell adhesion. Although the ER chaperone CRT is involved in the regulation of the Golgi-to-plasma membrane transportation of E-cadherin, the mechanism responsible for this phenomenon is still unclear. It remains possible that structural alterations in the Golgi stacks are the key factor responsible for altered E-cadherin trafficking and processing in CRT-knockdown cells.
A limitation of this study is that we did not use the primary-cultured normal trophoblast cells derived from human placentas to examine our hypothesis of this study. BeWo cells were derived from a choriocarcinoma and therefore are only partly a reflection of normal trophoblasts. In BeWo cells, syncytialization needs to be stimulated with forskolin or cAMP analogs, which are nonphysiologic agents in normal human placentation. To link our results with normal or pathologic human placentas, further experiments using the primary trophoblast cells are needed.
Collectively, the current study has demonstrated that the ER chaperone CRT plays a regulatory role in trophoblast syncytialization by ensuring appropriate control of E-cadherin protein synthesis and transportation in trophoblasts. Under CRT knockdown, syncytialization was suppressed via a reduction in cell-to-cell adhesion, which was induced through a reduction in cell surface E-cadherin expression. Therefore, the mechanism by which CRT is downregulated in STBs should be clarified to elucidate the placental dysfunctions that occur in cases of FGR. In studies of human third-trimester placentas, it has been suggested that upregulated ER stress might be involved in the pathological mechanisms underlying pregnancy-related disorders (7, 8, 12) . Further studies are needed to clarify how ER stress and CRT expression are involved in the pathology of placental disorders.
